Chemed Corp Stock Price, News & Analysis

VITAS Healthcare (NYSE:CHE) on November 25, 2025 released a video during National Care at Home Month that profiles caregiver Stacy Noland and her mother, Sonia Lindo, highlighting hospice care at home.

The video describes how VITAS teams enabled comfort and dignity during Lindo’s terminal illness, eased caregiver strain, and provided holistic support from nurses, aides, social workers, chaplains and bereavement specialists. Viewers are directed to watch Stacy’s story and to learn more at VITAS.com or call 800.93.VITAS.

Chemed (NYSE:CHE) declared a quarterly cash dividend of $0.60 per share, payable on December 5, 2025 to shareholders of record as of November 17, 2025. The dividend equals the amount paid in August 2025 and marks Chemed's 218th consecutive quarterly dividend during 54 years as a public company.

Chemed operates two subsidiaries: VITAS Healthcare (hospice services) and Roto-Rooter (plumbing and drain services). The release includes standard forward-looking statement cautions and a contact for investor inquiries.

Chemed Corporation (NYSE: CHE) will present at the UBS 2025 Global Healthcare Conference on Tuesday, November 11, 2025 at ~2:00 p.m. ET at PGA National Resort in Palm Beach Gardens, Florida.

The presentation will be webcast live and presentation materials will be posted on Chemed's Investor Relations website at www.chemed.com. A replay will be available within 24 hours and accessible for 90 days. Chemed operates two subsidiaries, VITAS Healthcare and Roto-Rooter. Forward-looking statements in the release are subject to risks and may change; Chemed does not assume an obligation to update them.

Chemed (NYSE:CHE) reported Q3 2025 revenue of $624.9M, up 3.1% year-over-year, with GAAP diluted EPS $4.46 (down 10.8%) and Adjusted diluted EPS $5.27 (down 6.6%).

VITAS net patient revenue was $407.7M (+4.2%), average daily census 22,327 (+2.5%), admissions 17,714 (+5.6%), and adjusted EBITDA excluding Medicare Cap $70.4M (margin 17.0%, -157 bps). Roto-Rooter revenue was $217.2M (+1.1%) with adjusted EBITDA $49.4M (margin 22.7%, -351 bps).

Cash and equivalents were $129.8M with no debt; the company repurchased 407,500 shares for $180.8M and reiterated 2025 adjusted EPS guidance of $22.00–$22.30.

Chemed Corporation (NYSE:CHE) has scheduled its third quarter 2025 financial results release for October 28, 2025, after the NYSE market close. The company will host a conference call and webcast on October 29, 2025, at 10:00 AM ET to discuss quarterly results and provide a business update.

Chemed operates two major subsidiaries: VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, the leading provider of plumbing and drain cleaning services in the United States.

VITAS Healthcare, a subsidiary of Chemed Corporation (NYSE:CHE), has been recognized as a 2025 Top Workplace in Healthcare by Top Workplaces USA. The company, which is one of only 57 healthcare organizations nationwide with over 1,000 employees to receive this distinction, earned the recognition based on employee feedback through confidential surveys measuring workplace culture drivers.

VITAS, employing nearly 12,000 professionals across 15 states and DC, serves 22,000 patients daily with hospice and palliative care services. The company continues to invest in workforce development through career programs, recognition platforms, and new technologies. This recognition follows their 2023 HRO Today Association award for excellence in employee experience in healthcare.

Chemed Corporation (NYSE:CHE), operator of VITAS Healthcare and Roto-Rooter, will present at the Jefferies 2025 Healthcare Services Conference on September 30, 2025, at 1:50 p.m. (CT) in Nashville.

The presentation will be accessible via live webcast through Chemed's website, with materials available for viewing. A replay will be available within 24 hours and remain accessible for 90 days. Chemed operates two major subsidiaries: VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, the leading provider of plumbing and drain cleaning services.

Chemed Corporation (NYSE:CHE) has announced two significant shareholder-friendly actions. The Board of Directors has authorized an additional $300 million for stock repurchases under its existing share repurchase program, which will be funded through operational cash flow and credit facility utilization.

Additionally, the company declared a quarterly cash dividend of 60 cents per share, representing a substantial 20% increase from the previous 50-cent dividend. This marks Chemed's 217th consecutive quarterly dividend in its 54-year history as a public company. The dividend is payable on August 29, 2025, to shareholders of record as of August 11, 2025.

Chemed Corporation (NYSE: CHE), operator of VITAS Healthcare and Roto-Rooter, reported mixed Q2 2025 results with consolidated revenue increasing 3.8% to $618.8 million, while GAAP EPS declined 23.2% to $3.57. The company's VITAS segment saw revenue growth of 5.8% to $396.2 million, driven by a 6.1% increase in Average Daily Census, while Roto-Rooter's revenue grew marginally by 0.6% to $222.6 million.

The company faces significant Medicare Cap challenges, with a projected $19 million Medicare Cap billing limitation in its Florida Combined program for 2025. Additionally, Chemed announced the departure of VITAS CEO Nicholas M. Westfall, to be succeeded by Joel L. Wherley. The company revised its 2025 guidance downward, now expecting adjusted EPS of $22.00 to $22.30, compared to previous guidance of $24.95 to $25.45.